New Medical Article About Elmiron-Related Vision Loss 3 Years After Elmiron Use
Written by: Lauren Schwab, Legal Assistant
Law Offices of Thomas J. Lamb, P.A.
A November 2020 article, "Potential new onset clinically detectable pentosan polysulfate maculopathy years after drug cessation", shows new research that further supports the idea that Elmiron-related vision loss can occur years after ending the use of Elmiron.
According to the Abstract for this recent article published by the Retinal Cases & Brief Reports medical journal, a 44-year-old female demonstrated signs of vision loss related to her Elmiron use which had ended nearly three years prior to her suspected diagnosis of maculopathy due to Elmiron:
A 44-year-old female with a 435g cumulative exposure to [Elmiron (pentosan polysulfate sodium)] presented 38-months after drug cessation with six months of worsening metamorphopsia and prolonged dark adaptation. Fundus exam and multimodal fundus imaging demonstrated characteristic features of [Elmiron (pentosan polysulfate)] maculopathy, and molecular testing was unremarkable. In contrast, color fundus photos of the same patient acquired at an outside facility 25 months prior did not display features consistent with [Elmiron (pentosan polysulfate)] maculopathy.
These findings are significant, as it shows the duration of time between the time a patient has stopped using Elmiron and the onset of Elmiron-related vision loss may be much longer than initially thought.
Additionally, as we have reported previously in our January 2021 blog post, "Elmiron Maculopathy Secondary to Pentosan Polysulfate (PPS) Toxicity: Medical Journal Article", it had been suggested that established maculopathy patients should be questioned regarding any Elmiron use in the past. This seems incredibly important now, as the onset of Elmiron-related vision loss may take place years after a patient has stopped using Elmiron.
Strictly Confidential, No Obligation.
As we have reported previously on our Elmiron Information Page, it is not necessary for the patient to have been using Elmiron regularly right up until the time when their Elmiron-related vision loss was diagnosed in order to file an Elmiron lawsuit. That is, unlike most other drug injury cases, the patient could have stopped using Elmiron months, now potentially years, before a medical doctor was able to diagnose their eye problem.
Our law firm is investigating possible Elmiron lawsuits for patients who have suffered vision loss due to Elmiron maculopathy. If we can be of assistance to you or someone else regarding an Elmiron vision loss case, you can send an email to Tom Lamb or you can call us on our toll-free number: 800-426-9535.
Drug Injury Watch: Side Effects News & Reports
Drug Injury Law: Medical & Legal Information